Vergis, J.; McCullumsmith, R. E. Pathway Enrichment and FDA-Approved Drug Repurposing Analysis for the Treatment of CTNNB1 Syndrome Modeled in an SH-SY5Y Cell Line. Translation 2025, 14 (S1). https://doi.org/10.46570/utjms-2025-1507.